SecBot SecBot
8-K ·Filed Oct 16, 2026

MBRX

Moleculin Biotech, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed10d 14h ago SEC0001437749-26-032762
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

Monitor the company's website or subsequent filings for any material updates from the investor presentation. No immediate trading catalyst from this filing alone.

DirectionNeutral
Confidencemedium
Horizonimmediate
Latest settled — T+5d
MBRX ▲ +15.91% at T+5d
NEUTRAL call +15.91% · α vs SPY +16.34% · entry $0.2804 → $0.3250
Next anchor: T+1d due 8d ago
Entry = T+0 close
Oct 16, 2026
via day close
T+1d
Pending
due 8d ago
T+5d
+15.91%
call +15.91% · α +16.34%
$0.3250
settled 4d ago
T+20d
Pending
in 17d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Moleculin Biotech filed an 8-K on October 16, 2026, to furnish a corporate investor presentation (Exhibit 99.1) posted on its website. The filing is a routine Regulation FD disclosure with no new financial data, guidance, or material events disclosed in the text of the 8-K itself.

Key Facts

  • Filed 8-K on October 16, 2026 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
  • Exhibit 99.1 is an investor presentation posted on the company's website; no financial figures or guidance are included in the filing text.
  • The presentation content is not extractable from the provided documents (only image files are listed).

Financial Impact

No financial data disclosed in the filing text.

Risk Factors

  • No new quantitative information to assess business performance or outlook.
  • Investor presentation may contain forward-looking statements not reflected in this filing.

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-032762
Document: mbrx20261015_8k.htm0001437749-26-032762
Document: 0001437749-26-032762-index-headers.html0001437749-26-032762
Document: 0001437749-26-032762-index.html0001437749-26-032762
Document: 0001437749-26-032762.txt0001437749-26-032762
30 reports for MBRX
Performance horizon
50% Hit rate @ T+20 7 of 14 directional calls Went positive at some point 10 of 16 best @ T+60▲ +1671.25%Jul 31, 2026
Filters
Rows
Reports for MBRX — sortable, filterable
TypeNow
Oct 20, 2026
6d ago
8-K
NEUTRAL ★ 4/10
$6.19awaiting T+20—$7.09 (+14.46%)
Oct 16, 2026
10d ago
8-K
NEUTRAL ★ 3/10
$0.2804awaiting T+20—$7.09 (+2426.75%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 4/10
$0.4139awaiting T+20—$7.09 (+1611.77%)
Oct 5, 2026
21d ago
8-K
NEUTRAL ★ 2/10
$0.4766awaiting T+20—$7.09 (+1386.57%)
Sep 29, 2026
27d ago
8-K
BULLISH ★ 6/10
$0.5264awaiting T+20—$7.09 (+1245.93%)
Sep 29, 2026
27d ago
Press Release
NEUTRAL ★ 6/10
$0.5264awaiting T+20—$7.09 (+1245.93%)
Sep 28, 2026
28d ago
8-K
BULLISH ★ 5/10
$0.5690 $7.09▲ +1145.17%▲ +1145.20%$7.09 (+1145.17%)
Sep 25, 2026
4w ago
8-K
NEUTRAL ★ 4/10
$0.6016 $6.50▲ +980.45%▲ +981.93%$7.09 (+1077.69%)
Sep 23, 2026
4w ago
8-K
MIXED ★ 5/10
$0.5279 $6.31▲ +1095.30%▲ +1094.61%$7.09 (+1242.11%)
Sep 18, 2026
5w ago
8-K
BEARISH ★ 8/10
$0.5202awaiting T+20—$7.09 (−1261.98%)
Showing 10 of 30

US Market Status

Market Closed — Opens in 9h 30m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 16, 2026